• ქართული
  • English
  • Bayer eyes 16 billion euros in 2022 adjusted EBITDA

    German drugmaker Bayer , which acquired seed company Monsanto this year, said it aimed to increase adjusted core earnings to 16 billion euros ($18.1 billion) in 2022, up from an expected 12.2 billion euros this year.

    Market Quotes by TradingView